JP Llanos Ackert, MD, C Ambrose, MD: New Data Support Tezepelumab for AsthmaMay 31st 2023
Investigators Dr. Jean-Pierre Llanos Ackert and Dr. Chris Ambrose share insight on the efficacy of tezepelumab in severe, uncontrolled asthma, and baseline predictors of enhanced response which support tezepelumab as a promising biologic treatment option.
Hollis O'Neal, MD: FDA-Approved Test Can Identify Early SepsisMay 30th 2023
Late-breaking data validates the FDA clearance of Cytovale's IntelliSep test, demonstrating its potential to aid in the early detection of sepsis in US emergency departments, with the aim of improving patient outcomes.
Hollis O'Neal, MD: Late Breaking Data on Diagnostic Test for Sepsis IntelliSepMay 29th 2023
Late-breaking data from ATS 2023 show new positive evidence of the innovative in-vitro diagnostic tool IntelliSep test that measures the viscoelastic properties of leukocytes, showing promising results for rapid sepsis diagnosis in EDs.
Victor Kim, MD: Addressing Comorbidities and Advancing COPD CareMay 28th 2023
Data indicates that addressing mood disorders in patients not only improves mood symptoms but also demonstrates positive effects on certain cardiac events, suggesting benefits for both mental and physical well-being.
Cedric Rutland, MD: Mechanisms Behind Immunology, Cellular CommunicationMay 23rd 2023
Dr. Rutland emphasizes the importance of understanding cellular communication and its potential to manipulate disease processes for patient benefit, including the observed link between ILD, inflammation, scarring, and pulmonary hypertension.
Dupilumab Improves Outcomes for COPD, Type 2 Inflammation in Randomized TrialMay 22nd 2023
Dupilumab demonstrates significant improvements in patients with COPD, type 2 inflammation by reducing exacerbations, improving lung function and quality of life, and alleviating respiratory symptoms.
Mucus Plugs in Medium- to Large-Sized Airways Increases Risk of Death in COPD PatientsMay 21st 2023
An analysis of the COPDGene Study presented at ATS 2023 suggests presence of mucus plugs in medium- to large-sized airways were associated with an increased risk of mortality in adjusted models.
Franziska Trudzinski, MD: Identifying Gender-Specific Pulmonary Disorders in COPDMay 18th 2022
Dr. Trudzinski speaks of the importance of diagnosing sex-specific pulmonary and extra-pulmonary comorbidities in women with COPD, as well as the lack of research regarding COPD prevalence in women.
Study Identifies Pathogenic Cell States, Transcriptional Programs Specific to AsthmaMay 18th 2022
In particular, airway epithelial cells (AEC) in allergic asthmatic (AA) were shown to upregulate mucus metaplasia, matrix-remodeling, and glycolytic programs while failing to upregulate antioxidant genes.
Edward Chen, MD: Amassing Data on Sarcoidosis Prevalence in Rural and Suburban Areas in the USMay 17th 2022
With this new decade-long cohort, Dr. Chen notes that researchers are "one step closer to a more accurate view of what sarcoidosis may be like in the United States", with has been suggested to be more prominent in African American communities.
David Au, MD, MS: Lifestyle Interventions for Weight Loss in Obese Patients with COPDMay 16th 2022
Dr. Au spoke of how the new data provides an opportunity to think about how lifestyle intervention focused on weight and moderate exercise can actually have meaningful impacts on patients with COPD.